COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,796 Articles (22,527 medRxiv, 8,269 bioRxiv)

Most recent first Previous |  Page 641: Articles 6401-6410  | Next

Social contact patterns during the COVID-19 pandemic in 21 European countries: evidence from a two-year study
Wong, K. L., Gimma, A., Coletti, P., CoMix Europe Working Group, , Faes, C., Beutels, P., Hens, N., Jaeger, V. K., Karch, A., Johnson, H., Edmunds, W. J., Jarvis, C. I.
10.1101/2022.07.25.22277998 — Posted: 2022-07-29
Projecting COVID-19 Cases and Subsequent Hospital Burden in Ohio
Khuda Bukhsh, W. R., Bastian, C. D., Wascher, M., Klaus, C., Sahai, S. Y., Weir, M. H., Kenah, E., Root, E., Tien, J. H., Rempala, G. A.
10.1101/2022.07.27.22278117 — Posted: 2022-07-29
Efficacy of a patient isolation hood in reducing exposure to airborne infectious virus in a simulated healthcare setting
Lee, L. Y. Y., Landry, S. A., Jamriska, M., Subedi, D., Joosten, S. A., Barr, J. J., Brown, R., Kevin, K., Schofield, R., Monty, J., Subbarao, K., McGain, F.
10.1101/2022.07.24.22277784 — Posted: 2022-07-29
Induction of poxviral immunity by synthetic MVA-based dual-antigen COVID-19 vaccine COH04S1
Chiuppesi, F., Zaia, J. A., Francisco, S. O., Ly, M., Wussow, F., Diamond, D. J.
10.1101/2022.07.26.22277958 — Posted: 2022-07-29
The COVID-19 pandemic impact on continuity of care provision on rare brain diseases and on Ataxia, Dystonia and PKU. A scoping review protocol
Cannizzo, S., Quoidbach, V., Giunti, P., Oertel, W., Pastores, G., Relja, M., Turchetti, G.
10.1101/2022.07.26.22277799 — Posted: 2022-07-29
The Association of Socioeconomic Status, the Concern for Catching Covid-19, and Anxiety Between Individuals with and without a Cancer History from a Cross-sectional Study
Zhang, X., Impact of COVID-19 on Behaviors across the Cancer Control Continuum in Ohio group, , Sasmal, S., Yu, M., Bernardo, B., Adeyanju, T., Paskett, E.
10.1101/2022.07.26.22278080 — Posted: 2022-07-29
Computer Simulation of the interaction between SARS-CoV-2 Spike Protein and the Surface of Coinage Metals
Sahihi, M., Faraudo, J.
10.1101/2022.07.28.501856 — Posted: 2022-07-29
Neutralization of SARS-CoV-2 Omicron sublineages by 4 doses of mRNA vaccine
Xie, X., Zou, J., Liu, M., Ren, P., Shi, P.-Y.
10.1101/2022.07.29.502055 — Posted: 2022-07-29
A multispecific antibody confers pan-reactive SARS-CoV-2 neutralization and prevents immune escape
Misasi, J., Wei, R. R., Wang, L., Pegu, A., Wei, C.-J., Oloniniyi, O., Zhou, T., Zhao, B., Choe, M., Boruszczak, M., Chen, M., Leung, K., Li, J., Yang, E. S., Yang, Z.-Y., Zhang, Y., Carlton, K., Harris, D. R., Ivleva, V. B., Lei, P., Liu, C., Longobardi, L., Olia, A. S., Shi, W., Wolff, J. J., Gall, J., Koup, R. A., Kwong, P. D., Mascola, J. R., Nabel, G. J., Sullivan, N. J.
10.1101/2022.07.29.502029 — Posted: 2022-07-29
Psychological impacts of COVID-19 outbreak in Ethiopia: a systematic review and meta-analysis
Lankrew, T., Gelaw, B.
10.1101/2022.07.27.22278107 — Posted: 2022-07-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).